Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CYPRESS BIOSCIENCE INC (CYPB) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/04/2011 MW FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
12/15/2010 BW Cypress Bioscience Agrees To Be Acquired by Ramius LLC and Royalty Pharma for $6.50 Per Share in Cash
12/10/2010 BW Cypress Bioscience Board of Directors Confirms Receipt of Revised Ramius LLC Offer in Connection with Strategic Review Process
11/09/2010 MW Cypress Bioscience Announces Third Quarter 2010 Financial Results
11/03/2010 MW Cypress Bioscience, Inc. to Present at Oppenheimer 21st Annual Healthcare Conference
09/28/2010 MW Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer
09/22/2010 MW Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference
09/15/2010 MW Cypress Bioscience, Inc. to Present at Baird's 2010 Health Care Conference
08/26/2010 MW Cypress Bioscience Licenses Alexza Pharmaceutical's Staccato(R) Nicotine

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy